| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/16/2009 | US20090181060 Skin-care compositions |
| 07/16/2009 | US20090181058 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 07/16/2009 | US20090181039 Conjugates with reduced adverse systemic effects |
| 07/16/2009 | US20090181032 facilitate drug delivery of other molecules; e.g. use intraocularly in eye surgery, glaucoma, retinopathy treatments |
| 07/16/2009 | US20090181013 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 07/16/2009 | US20090180977 Controlled release compositions |
| 07/16/2009 | US20090180973 Compositions of oxo-terpene derivatives and process for preparing the same |
| 07/16/2009 | US20090180972 Compositions of oxo-terpene derivatives and process for preparing the same |
| 07/16/2009 | US20090180963 Formulations for use in medical and diagnostic procedures |
| 07/16/2009 | US20090178673 Actuation Indicator for a Dispensing Device |
| 07/16/2009 | DE10214226B4 Wirkstoffträger, Verfahren zu dessen Herstellung und Verwendung Drug carriers, methods for its preparation and use |
| 07/16/2009 | CA2711862A1 Composition for improving nutritional status of the elderly, reducing frequency of fever of the elderley and/or increasing immunocompetence of the elderly |
| 07/16/2009 | CA2711663A1 Liquid antiseptic compositions containing iodine and a sugar and/or sugar alcohol |
| 07/16/2009 | CA2711561A1 Insulin formulations for insulin release as a function of tissue glucose levels |
| 07/16/2009 | CA2711475A1 Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release |
| 07/16/2009 | CA2711474A1 Coated pharmaceutical or nutraceutical preparation with enhanced pulsed active substance release |
| 07/16/2009 | CA2711473A1 Coated pharmaceutical or nutraceutical preparation with enhanced active substance release in the colon |
| 07/16/2009 | CA2711217A1 Antimicrobial compositions |
| 07/16/2009 | CA2711114A1 Topical compositions for the controlled delivery of proteins and peptides |
| 07/16/2009 | CA2710841A1 Y-shaped polyethylene glycol modified g-csf, the preparation and use thereof |
| 07/16/2009 | CA2706931A1 Oral pharmaceutical dosage forms |
| 07/16/2009 | CA2705285A1 Pharmaceutical formulations |
| 07/16/2009 | CA2702992A1 Methods of inhibiting bacterial virulence and compounds relating thereto |
| 07/15/2009 | EP2078729A1 PPY agonists and uses thereof |
| 07/15/2009 | EP2078527A1 Aqueous liquid preparation comprising gatifloxacin |
| 07/15/2009 | EP2078526A1 Aqueous liquid preparation having improved intraocular gatifloxacin penetration |
| 07/15/2009 | EP2078524A1 Adhesive skin patch |
| 07/15/2009 | EP2078460A1 Process for preparing concentrate thickener compositions |
| 07/15/2009 | EP2077861A2 A drug-release composition having a therapeutic carrier |
| 07/15/2009 | EP2077860A2 Novel psychotropic agents having glutamate nmda activity |
| 07/15/2009 | EP2077840A1 Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof |
| 07/15/2009 | EP2077834A2 Formulations of phospholipase enzyme inhibitors |
| 07/15/2009 | EP1994062B1 Aryl/alkyl vinyl sulfone hyaluronic acid derivatives |
| 07/15/2009 | EP1891143A4 Polymer-based serum albumin substitute |
| 07/15/2009 | EP1752162B1 Collagen-polyvinylpyrrolidone for the treatment of osteoarthritis |
| 07/15/2009 | EP1715893B1 Direct compression formulation and process |
| 07/15/2009 | EP1675563A4 Emulsive composition containing dapsone |
| 07/15/2009 | EP1446099B1 Injectable depot composition |
| 07/15/2009 | EP1395278B1 Ocular tear growth factor-like protein |
| 07/15/2009 | EP1389118B1 Single-daily-dose antidiabetic oral pharmaceutical form comprising a biguanide and at least another active principle |
| 07/15/2009 | EP1292381B1 Process and device for producing liquid dosage formulations |
| 07/15/2009 | EP1214097B1 Nucleic acids encoding polyepitope polypeptides |
| 07/15/2009 | CN101484189A Fermentation and purification of ACTINOMADURA chromoprotein and related species |
| 07/15/2009 | CN101484188A Pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent |
| 07/15/2009 | CN100513417C Aqueous suspensions of ciclesonide for nebulisation |
| 07/15/2009 | CN100513416C Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 07/15/2009 | CN100512879C Conjugate having cleavable linkage for use in liposome |
| 07/15/2009 | CN100512878C Medicament for treating acarodermatitis of human face and preparation method thereof |
| 07/15/2009 | CN100512877C Germ-free medicinal compositions |
| 07/15/2009 | CN100512876C Coated metal pyrithione particles for treatment of microorganisms |
| 07/15/2009 | CN100512810C Premixed amiodarone parenteral solution and method for making the same |
| 07/15/2009 | CN100512807C Pharmaceutical for preventing and curing acute gout, tumor and hepatic/pulmonary fibrosis and preparation method thereof |
| 07/15/2009 | CN100512798C Method for preparing submicron particle suspensions |
| 07/14/2009 | US7560534 For use in therapeutic and diagnostic procedures |
| 07/14/2009 | US7560493 Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active principle and at least one N-vinylimidazole polymer or copolymer |
| 07/14/2009 | US7560492 stent has a coatings containing a copolymer of polysulfone and an elastomeric polymer, selecting from additional monomers as isobutylene, butyl methacrylate, lauryl methacrylate, or polyethersulfone copolymer, acrylated resins; mechanical properties, optimal permeability and good biocompatibility |
| 07/14/2009 | US7560490 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof |
| 07/14/2009 | US7560487 In particular, kidneys |
| 07/14/2009 | US7560444 Formulations comprising low molecular weight heparin and a therapeutic, prophylactic or diagnostic agent; improved bioavailability; side effect reduction |
| 07/14/2009 | US7560424 Localize to a specific subcellular compartment such as the lysosome are provided. The targeted therapeutics include a therapeutic agent and a targeting moiety that binds a receptor on an exterior surface of the cell, permitting proper |
| 07/14/2009 | US7560160 Multifunctional particulate material, fluid, and composition |
| 07/14/2009 | US7560121 fluphenazine dihydrochloride-containing transdermal therapeutic system (TTS) which releases at least desired active agent to the human skin, comprises an enhancer and has a skin-facing pressure-sensitive adhesive layer based on polymers which are pure hydrocarbons; treating schizophrenia and psychoses |
| 07/14/2009 | US7560120 Using citric acid esters or ethers |
| 07/14/2009 | US7560110 Radioimmunotherapy; antibody fragment having at least one arm that specifically binds a targeted tissue and at least one other arm that specifically binds a targetable construct |
| 07/14/2009 | CA2487834C Orally disintegrating tablets and process for obtaining them |
| 07/14/2009 | CA2472392C Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof |
| 07/14/2009 | CA2402988C Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent |
| 07/14/2009 | CA2390092C Solid dispersion pharmaceutical formulations |
| 07/14/2009 | CA2366754C Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants |
| 07/14/2009 | CA2306560C Topical antifungal composition |
| 07/14/2009 | CA2262972C Compositions of plant carbohydrates as dietary supplements |
| 07/14/2009 | CA2242542C Compositions and methods for therapeutic use |
| 07/14/2009 | CA2235721C Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 07/14/2009 | CA2183543C Sexual steroid-containing transdermal therapeutic systems |
| 07/09/2009 | WO2009086296A2 Counter-pressure filtration of proteins |
| 07/09/2009 | WO2009086106A1 Use of podocan protein in treating cardiovascular diseases |
| 07/09/2009 | WO2009086098A1 Porous microparticles for injection and processes for forming the same |
| 07/09/2009 | WO2009086073A1 Stabilized glycerophosphate-containing surgical irrigating solution |
| 07/09/2009 | WO2009086067A2 Particles for injection and processes fo forming the same |
| 07/09/2009 | WO2009086055A1 Enhancing photostabilization of oxymetazoline |
| 07/09/2009 | WO2009085302A2 Method and multilayered device for controlled topical delivery of therapeutic agents to the skin |
| 07/09/2009 | WO2009085106A1 Resin assisted capture of cysteine-modified proteins/peptides and determination of presence and location of modification |
| 07/09/2009 | WO2009084975A1 Composition exhibiting high osmotic antimicrobial, anti-inflammatory and regeneration activity |
| 07/09/2009 | WO2009084680A1 Gold nanoparticle composition, dna chip, near infrared absorbent, drug carrier for drug delivery system (dds), coloring agent, biosensor, cosmetic, composition for in vivo diagnosis and composition for therapeutic use |
| 07/09/2009 | WO2009084678A1 Oral cavity disintegrating tablet and method of producing the same |
| 07/09/2009 | WO2009084659A1 Solution preparation containing antibody at high concentration |
| 07/09/2009 | WO2009084611A1 Antipruritic sheet |
| 07/09/2009 | WO2009084588A1 Water-containing composition which can be used as external composition |
| 07/09/2009 | WO2009084482A1 Composition comprising sesamin component and quercetin glycoside |
| 07/09/2009 | WO2009084234A1 Sheet preparation to be applied to the human body |
| 07/09/2009 | WO2009084216A1 Oral powder and granular antitumor agent |
| 07/09/2009 | WO2009084041A2 Pharmaceutical compositions of dexibuprofen |
| 07/09/2009 | WO2009084021A2 Ophthalmic composition comprising a prostaglandin |
| 07/09/2009 | WO2009084017A2 Taste-masked orally disintegrating tablets of memantine hydrochloride |
| 07/09/2009 | WO2009083880A1 Transglutaminases binding fusion protein, compositions comprising thereof, micro-spheres comprising thereof uses and methods |
| 07/09/2009 | WO2009083804A2 Improved fibronectin-based binding molecules and their use |
| 07/09/2009 | WO2009083794A1 Pharmaceutical compositions containing an inclusion complex formed by disulfiram and a cyclodextrin, which can be used in the treatment of alcohol and cocaine dependence |
| 07/09/2009 | WO2009083793A1 Inclusion complex formed by disulfiram and a cyclodextrin, which can be used in the treatment of alcohol and cocaine dependence |
| 07/09/2009 | WO2009083738A2 Rna delivery vehicles |
| 07/09/2009 | WO2009083686A1 Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes |